{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lactate+infusion", "query": { "intervention": "Lactate infusion" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 40, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lactate+infusion&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T20:26:17.817Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06126354", "title": "Dexamethasone/Pancreatic Clamp P&F", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Insulin Resistance", "Prediabetic State", "Non-Alcoholic Fatty Liver Disease", "Overweight and Obesity" ], "interventions": [ { "name": "Insulin human", "type": "DRUG" }, { "name": "Octreotide Acetate", "type": "DRUG" }, { "name": "Glucagon", "type": "DRUG" }, { "name": "Human Growth Hormone", "type": "DRUG" }, { "name": "Dexamethasone Oral", "type": "DRUG" }, { "name": "[6,6-2H2] D-glucose", "type": "OTHER" }, { "name": "20% D-glucose (aq)", "type": "DRUG" }, { "name": "BOOST Plus", "type": "DIETARY_SUPPLEMENT" }, { "name": "Harvard Apparatus PHD ULTRA CP syringe pump", "type": "DEVICE" }, { "name": "Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer", "type": "DEVICE" }, { "name": "Normal saline", "type": "OTHER" }, { "name": "Human albumin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2024-07-01", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2024-07-10", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06126354" }, { "nct_id": "NCT03133767", "title": "Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fluid Loss", "Symptom Complex, Triple", "Emergencies" ], "interventions": [ { "name": "Lactated Ringer Solution", "type": "DRUG" }, { "name": "Normal Saline 0.9% Infusion Solution Bag", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicholas M Mohr", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 157, "start_date": "2017-05-23", "completion_date": "2017-11-02", "has_results": true, "last_update_posted_date": "2018-09-11", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03133767" }, { "nct_id": "NCT05724134", "title": "Pancreatic Clamp in NAFLD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Insulin Resistance", "Prediabetic State", "Hyperinsulinemia", "Non-Alcoholic Fatty Liver Disease", "Obesity" ], "interventions": [ { "name": "Insulin human", "type": "DRUG" }, { "name": "Octreotide Acetate", "type": "DRUG" }, { "name": "Glucagon", "type": "DRUG" }, { "name": "Growth Hormone, Human", "type": "DRUG" }, { "name": "[6,6-2H2] D-glucose", "type": "OTHER" }, { "name": "20% D-glucose (aq)", "type": "DRUG" }, { "name": "BOOST Plus", "type": "DIETARY_SUPPLEMENT" }, { "name": "CORE Bar", "type": "DIETARY_SUPPLEMENT" }, { "name": "Harvard Apparatus PHD ULTRA CP syringe pump", "type": "DEVICE" }, { "name": "Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 18, "start_date": "2023-08-29", "completion_date": "2025-09-24", "has_results": false, "last_update_posted_date": "2026-01-12", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05724134" }, { "nct_id": "NCT05975021", "title": "A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cardiogenic Shock" ], "interventions": [ { "name": "Istaroxime", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Windtree Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20, "start_date": "2024-06-01", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2025-08-20", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Portland, Oregon", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05975021" }, { "nct_id": "NCT05207397", "title": "Lactate for Energy and Neurocognition", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Aging", "Alzheimer Disease" ], "interventions": [ { "name": "Lactate infusion", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "60 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "60 Years to 95 Years" }, "enrollment_count": 24, "start_date": "2023-04-12", "completion_date": "2024-03-29", "has_results": false, "last_update_posted_date": "2025-05-14", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05207397" }, { "nct_id": "NCT03434028", "title": "Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Septic Shock" ], "interventions": [ { "name": "Early Vasopressors", "type": "DRUG" }, { "name": "Early Fluids", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1563, "start_date": "2018-03-07", "completion_date": "2022-08-24", "has_results": true, "last_update_posted_date": "2023-07-06", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 50, "location_summary": "Tucson, Arizona • Fresno, California • Los Angeles, California + 36 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03434028" }, { "nct_id": "NCT01587963", "title": "High Dose Vitamin C in the Critically Ill Patient", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Shock" ], "interventions": [ { "name": "Ascorbic Acid", "type": "DRUG" }, { "name": "Ringers Lactate or Normal Saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2013-02", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-05-11", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01587963" }, { "nct_id": "NCT03101891", "title": "Renal Anhydramnios Fetal Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anhydramnios", "Potter Syndrome", "Lung Hypoplasia", "Multicystic Dysplastic Kidney", "Multicystic Renal Dysplasia, Bilateral", "Lower Urinary Tract Obstructive Syndrome", "Fetal Renal Anomaly" ], "interventions": [ { "name": "Serial amnioinfusions with isotonic fluid", "type": "PROCEDURE" }, { "name": "Spinal needle", "type": "DEVICE" }, { "name": "Isotonic fluid", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 55, "start_date": "2018-12-21", "completion_date": "2026-02-27", "has_results": true, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 9, "location_summary": "Los Angeles, California • San Francisco, California • Stanford, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03101891" }, { "nct_id": "NCT02467387", "title": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Ischemic Heart Failure" ], "interventions": [ { "name": "Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)", "type": "DRUG" }, { "name": "Lactated Ringer's Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CardioCell LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2014-06-01", "completion_date": "2017-05-11", "has_results": true, "last_update_posted_date": "2020-01-07", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 5, "location_summary": "Washington D.C., District of Columbia • Atlanta, Georgia • Chicago, Illinois + 2 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Stony Brook", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02467387" }, { "nct_id": "NCT07212595", "title": "Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Kidney Injury", "Mechanical Ventilation" ], "interventions": [ { "name": "Amino Acid infusion", "type": "DRUG" }, { "name": "Lactated ringers solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana Fuhrman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 30, "start_date": "2026-07-08", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-07T20:26:17.817Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07212595" } ] }